首页 正文

Therapeutic strategies of recurrent glioblastoma and its molecular pathways 'Lock up the beast'

{{output}}
Glioblastoma multiforme (GBM) has a poor prognosis-despite aggressive primary treatment composed of surgery, radiotherapy and chemotherapy, median survival is still around 15 months. It starts to grow again after a year of treatment and eventually nothing is e... ...